參考文獻(xiàn)/References:
[1] 張乃崢.臨床風(fēng)濕病學(xué)[M].上海:上海科學(xué)技術(shù)出版社,1999:155-157.
[2] 中華中醫(yī)藥學(xué)會(huì).中醫(yī)內(nèi)科常見病診療指南[M].北京:中國(guó)中醫(yī)藥出版社出版,2008:135.
[3] 鄭筱萸.中藥新藥臨床研究指導(dǎo)原則[M].北京:中國(guó)醫(yī)藥科技出版社,2002:119-123.
[4] 于孟學(xué).風(fēng)濕科主治醫(yī)生1053問(wèn)[M].北京:中國(guó)協(xié)和醫(yī)科大學(xué)出版社,2010:253-255.
[5] Sharma N,Sharma V,Masood T,et al.Usage of conventional PCR technology for the detection of HLA-B27 allele: a significant molecular marker of ankylosing spondylitis[J].Indian J Clin Biochem,2013,28(2):189-192.
[6] Qian BP,Jiang J,Ji ML,et al.Lack of associations between two previously identified susceptible single nucleotide polymorphisms of interleukin-23 receptor gene and ankylosing spondylitis:a replication study in a Chinese Han population[J].BMC Musculoskelet Disord,2013,14(14):190.
[7] 方翼,黃烽.抗強(qiáng)直性脊柱炎藥物的研究進(jìn)展[J].解放軍藥學(xué)學(xué)報(bào),2008,24(6):521-524.
[8] Hsia EC,Cush JJ,Matteson EL,et al.Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab,a human anti-tumor necrosis factor antibody,in Phase III clinical trials[J].Arthritis Care Res,2013,65(2):309-313.
[9] Hsia EC,Schluger N,Cush JJ,et al.Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab,a human anti-tumor necrosis factor antibody,in patients with rheumatoid arthritis,psoriatic arthritis,or ankylosing spondylitis[J].Arthritis Rheum,2012,64(7):2068-2077.
[10] Van Der Heijde D,Salonen D,Weissman BN,et al.Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years[J].Arthritis Res Ther,2009,11(4):R127.
[11] 車萍,季旭明,梁粟,等.獨(dú)活寄生湯對(duì)佐劑性關(guān)節(jié)炎大鼠的抗炎鎮(zhèn)痛作用及血清中5-HTP,5-HIAA的影響[J].中國(guó)實(shí)驗(yàn)方劑學(xué)雜志,2014,20(19):170-173.
[12] 馬衛(wèi)國(guó),劉慧,張春艷,等.加味獨(dú)活寄生湯對(duì)膠原誘導(dǎo)性關(guān)節(jié)炎大鼠關(guān)節(jié)炎癥的影響[J].中國(guó)實(shí)驗(yàn)方劑學(xué)雜志,2014,20(18):155-159.
[13] 李西海,張翼,葉蕻芝,等.獨(dú)活寄生湯治療風(fēng)寒濕痹型膝骨關(guān)節(jié)炎的機(jī)制[J].中醫(yī)正骨,2012,24(1):68-71.
[14] 荀培軍,艾有利.獨(dú)活寄生湯在骨科疾病治療中的應(yīng)用[J].中醫(yī)正骨,2014,26(12):56-58.
[15] 馮建邦,高根德.中醫(yī)外治法治療強(qiáng)直性脊柱炎研究進(jìn)展[J].中國(guó)中醫(yī)骨傷科雜志,2009,17(8):68-70.
[16] 赫軍,諸葛天諭,李冬冬,等.中藥內(nèi)服聯(lián)合針刺與埋針?lè)ㄖ委熡啄陱?qiáng)直性脊柱炎[J].中醫(yī)正骨,2016,28(1):41-42.
相似文獻(xiàn)/References:
[1]閻曉霞,任之強(qiáng),仝允輝,等.布魯氏菌性脊柱炎3例[J].中醫(yī)正骨,2015,27(06):64.
[2]趙偉光,劉振武,劉利,等.強(qiáng)直性脊柱炎合并右側(cè)股骨頭和股骨頸骨溶解癥1例[J].中醫(yī)正骨,2015,27(01):75.
[3]黃建武,黃建華,黃影.腫瘤壞死因子-α在強(qiáng)直性脊柱炎活動(dòng)期患者中的表達(dá)[J].中醫(yī)正骨,2013,25(11):22.
[4]張董喆,孔超,張建福.針刺夾脊穴結(jié)合督灸治療強(qiáng)直性脊柱炎[J].中醫(yī)正骨,2014,26(07):58.
[5]吳建國(guó).強(qiáng)直性脊柱炎并發(fā)脊柱骨折的影像學(xué)表現(xiàn)[J].中醫(yī)正骨,2013,25(06):31.
[6]謝國(guó)華,薛峰,楊建平,等.強(qiáng)直性脊柱炎脊柱應(yīng)力性骨折的診斷[J].中醫(yī)正骨,2012,24(12):72.
[7]張萬(wàn)義,張永紅,王笑青.雙醋瑞因膠囊聯(lián)合柳氮磺胺吡啶腸溶片與右旋布洛芬膠囊治療強(qiáng)直性脊柱炎[J].中醫(yī)正骨,2012,24(06):26.
ZHANG Wan-yi*,ZHANG Yong-hong,WANG Xiao-qing.*.Study on the curative effects of diacerein capsules combined with sulfasalazine enteric-coated tablets and dextral ibuprofen capsules in the treatment of ankylosing spondylitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(06):26.
[8]黃建華,黃建武,陳金春,等.早期強(qiáng)直性脊柱炎血管內(nèi)皮生長(zhǎng)因子、C反應(yīng)蛋白
表達(dá)水平的臨床研究[J].中醫(yī)正骨,2012,24(02):9.
HUANG Jian-hua*,HUANG Jian-wu,CHEN Jin-chun,et al.Clinical research on the expression of VEGF、CRP in early ankylosing spondylitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(06):9.
[9]王笑青,張永紅,王玉麗,等.常規(guī)藥物口服配合中藥離子導(dǎo)入治療強(qiáng)直性脊柱炎肌腱附著點(diǎn)炎[J].中醫(yī)正骨,2011,23(10):18.
WANG Xiao-qing*,ZHANG Yong-hong,WANG Yu-li,et al.A study on the curative effects of oral conventional drugs combined with traditional Chinese medicine iontophoresis on ankylosing spondylitis tendon enthesitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(06):18.
[10]劉紅軍.單節(jié)段楔形截骨結(jié)合椎弓根A-F系統(tǒng)內(nèi)固定
治療強(qiáng)直性脊柱炎脊柱后凸畸形[J].中醫(yī)正骨,2011,23(09):65.
[11]戴霞華,李寅潔.指導(dǎo)性功能鍛煉在兒童強(qiáng)直性脊柱炎護(hù)理中的應(yīng)用[J].中醫(yī)正骨,2015,27(10):78.
[12]張夢(mèng)雨,鮑鐵周,田江波.督脈隔姜灸聯(lián)合柳氮磺吡啶腸溶片口服及
功能鍛煉治療強(qiáng)直性脊柱炎[J].中醫(yī)正骨,2015,27(09):44.
[13]赫軍,諸葛天諭,李冬冬,等.中藥內(nèi)服聯(lián)合針刺與埋針?lè)ㄖ委熡啄陱?qiáng)直性脊柱炎[J].中醫(yī)正骨,2016,28(01):41.
[14]張遂連,袁星星.自我管理在強(qiáng)直性脊柱炎患者門診護(hù)理中的應(yīng)用[J].中醫(yī)正骨,2017,29(03):79.
[15]李現(xiàn)林,薛華珍,陳星,等.口服通痹舒筋丸治療強(qiáng)直性脊柱炎寒濕痹阻證[J].中醫(yī)正骨,2017,29(05):31.
[16]龔家川.影響強(qiáng)直性脊柱炎患者髖關(guān)節(jié)受累的危險(xiǎn)因素分析[J].中醫(yī)正骨,2017,29(06):25.
GONG Jiachuan.Analysis of risk factors for affection of hip joint in patients with ankylosing spondylitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(06):25.
[17]黃小龍,全仁夫,胡華輝,等.HLA-B2704基因型強(qiáng)直性脊柱炎患者來(lái)源的人誘導(dǎo)多能干細(xì)胞體系的建立[J].中醫(yī)正骨,2017,29(12):11.
HUANG Xiaolong,QUAN Renfu,HU Huahui,et al.Establishment of human-induced pluripotent stem cells system originated from patients with HLA-B2704 genotypic ankylosing spondylitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(06):11.
[18]李洛宜,張依山,王笑青,等.系列化視頻在強(qiáng)直性脊柱炎健康教育中的應(yīng)用[J].中醫(yī)正骨,2018,30(03):78.
[19]任偉凡,胡勁濤,全仁夫,等.強(qiáng)直性脊柱炎易感基因的相關(guān)研究進(jìn)展[J].中醫(yī)正骨,2019,31(04):48.
[20]楊愛(ài)娟,徐保平,王曉濤.新風(fēng)膠囊治療強(qiáng)直性脊柱炎臨床療效的系統(tǒng)評(píng)價(jià)[J].中醫(yī)正骨,2020,32(07):12.
YANG Aijuan,XU Baoping,WANG Xiaotao.Clinical efficacy of Xinfeng(新風(fēng))capsule for treatment of ankylosing spondylitis:a systematic review[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2020,32(06):12.